CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 21 - 30 of 649
Study Numbersort descending Lead Group Study Title CIRB Study Status
10066 ETCTN A Phase 1 / 2 Study of Olaparib in Combination with Ramucirumab in Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma Adult CIRB - Early Phase Emphasis Available to Open
10067 ETCTN A randomized phase 2 trial of cediranib and olaparib compared to bevacizumab in patients with recurrent glioblastoma who have not received prior VEGF therapy Adult CIRB - Early Phase Emphasis Available to Open
10070 ETCTN Phase 1/2 Study of Navitoclax Plus Vistusertib in Patients with Relapsed Small Cell Lung Cancer (SCLC) and Other Solid Tumors Adult CIRB - Early Phase Emphasis Available to Open
10075 ETCTN A Phase 1B Study of AMG-232 in Combination with Decitabine in Acute Myeloid Leukemia Adult CIRB - Early Phase Emphasis Available to Open
10076 ETCTN A Phase 1 Dose-Escalation And Exploratory Dose Expansion Study Of AMG 232 In Combination With Carfilzomib, Lenalidomide, And Dexmethasone In Relapsed And/Or Refractory Myeloma Adult CIRB - Early Phase Emphasis Available to Open
10089 ETCTN A Randomized Phase 2 Study of CDX-1127 (Varlilumab) in Combination with Nivolumab in Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Adult CIRB - Early Phase Emphasis Available to Open
10096 ETCTN A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE) Adult CIRB - Early Phase Emphasis Available to Open
10100 ETCTN A Randomized, Phase 2 Trial to Evaluate the Safety and Efficacy of Eribulin Mesylate in Combination with Atezolizumab Compared to Atezolizumab Alone in Subjects with Locally Advanced or Metastatic Transitional Cell Urothelial Cancer Where Platinum-Based Treatment is Not an Option Adult CIRB - Early Phase Emphasis Available to Open
10104 ETCTN A Randomized Phase 2 Study of Cabozantinib in Combination with Nivolumab in Advanced, Recurrent Metastatic Endometrial Cancer. Adult CIRB - Early Phase Emphasis Available to Open
10106 ETCTN A phase I and randomized phase II study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory lymphomas Adult CIRB - Early Phase Emphasis Available to Open
Displaying 21 - 30 of 649